Nuvalent, Inc. recently reported new clinical and preclinical data for its investigational ROS1-selective inhibitor zidesamtinib at the AACR 2026 meeting, alongside confirmation that the FDA has ...
StockStory.org on MSN
Research tools & consumables stocks Q4 results: Benchmarking Revvity (NYSE:RVTY)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
Morning Overview on MSN
Study links beta cell cholecystokinin to obesity-driven pancreatic cancer
Researchers have identified a specific hormone produced by pancreatic beta cells as a direct driver of obesity-linked ...
Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.
Vancouver, British Columbia - March 19, 2026 - PRESSADVANTAGE - Retreat Spa at Hyatt Regency Vancouver has announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results